Brochure
7 Sep 2021
Company presentation
PDF 14.9 MB
Content provided by our supplier
Neogen N.V.
-
Country/Region:Belgium
-
On CPHI since:2015
-
Certificates:3
-
Employees:100 - 249
Company types
Other Content from Neogen N.V. (1)
-
News Milla Pharmaceuticals Inc. Announces Approval of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced that it has received abbreviated new drug application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for its Generic Version of Magnesium Sulfate in Water for Injection, 2 g/50 mL (40 mg/mL), 4 g/100 mL (40 mg/mL), and 4 g/50 mL (80 mg/mL), in Non-PVC, Single-Patient Use Containers (Magnesium Sulfate Injection).